Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Astrocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03573986
What this trial is testing

Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment

Who this might be right for
Recurrent Glioblastoma
Abramson Cancer Center at Penn Medicine 2
Testing effectiveness (Phase 2)Study completedNCT00424060
What this trial is testing

Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 38
Early research (Phase 1)Study completedNCT00100880
What this trial is testing

Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+23 more
National Cancer Institute (NCI) 45
Early research (Phase 1)Study completedNCT00003876
What this trial is testing

Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Barrett Cancer Center
Not applicableStudy completedNCT04566185
What this trial is testing

Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Centre Hospitalier Universitaire de Nīmes 14
Testing effectiveness (Phase 2)Ended earlyNCT01189240
What this trial is testing

RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Study completedNCT01738646
What this trial is testing

Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients

Who this might be right for
Recurrent Glioblastoma MultiformeMalignant GliomaAdult Brain Tumor
Duke University 48
Early research (Phase 1)WithdrawnNCT01189513
What this trial is testing

SCH-900105 in Recurrent Glioblastoma

Who this might be right for
Glioblastoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT01445691
What this trial is testing

More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery

Who this might be right for
Benign Neoplasms, BrainBrain CancerBrain Neoplasms, Benign+12 more
Constantinos Hadjipanayis
Testing effectiveness (Phase 2)Looking for participantsNCT06894225
What this trial is testing

Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature

Who this might be right for
Recurrent Glioblastoma
National Neuroscience Institute 12
Early research (Phase 1)Looking for participantsNCT03383978
What this trial is testing

Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma

Who this might be right for
Glioblastoma
Johann Wolfgang Goethe University Hospital 42
Testing effectiveness (Phase 2)Ended earlyNCT00075491
What this trial is testing

Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT00004078
What this trial is testing

Irinotecan in Treating Children With Refractory Solid Tumors

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+18 more
Children's Oncology Group 181
Not applicableActive Not RecruitingNCT07448480
What this trial is testing

Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant Gliomas

Who this might be right for
Recurrent Malignant GliomaGlioblastomaAnaplastic Astrocytoma+1 more
Blokhin's Russian Cancer Research Center 1,000
Testing effectiveness (Phase 2)Ended earlyNCT03856099
What this trial is testing

TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab

Who this might be right for
Recurrent Glioblastoma
PharmAbcine 19
Early research (Phase 1)Study completedNCT00890032
What this trial is testing

Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Central Nervous System Neoplasm
John Sampson 50
Testing effectiveness (Phase 2)Study completedNCT03027388
What this trial is testing

Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma

Who this might be right for
Astrocytoma, Grades II, III and IVGlioblastoma MultiformeGiant Cell Glioblastoma+2 more
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT04729959
What this trial is testing

Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma

Who this might be right for
Diffuse Astrocytoma, IDH-WildtypeRecurrent Glioblastoma
National Cancer Institute (NCI) 61
Testing effectiveness (Phase 2)Study completedNCT02120287
What this trial is testing

Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme

Who this might be right for
Glioblastoma MultiformeGlioblastoma - Category
Ajay Niranjan 16
Early research (Phase 1)Study completedNCT00020150
What this trial is testing

Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Cancer Institute (NCI)
Next Page